John G. McHutchison

2019

In 2019, John G. McHutchison earned a total compensation of $5.4M as Former Chief Scientific Officer, Head of Research and Development at Gilead Sciences, a 25% decrease compared to previous year.

Compensation breakdown

Option Awards$999,978
Salary$640,096
Stock Awards$2,683,888
Other$1,112,000
Total$5,435,962

McHutchison received $2.7M in stock awards, accounting for 49% of the total pay in 2019.

McHutchison also received $1M in option awards, $640.1K in salary and $1.1M in other compensation.

Rankings

In 2019, John G. McHutchison's compensation ranked 1,965th out of 13,971 executives tracked by ExecPay. In other words, McHutchison earned more than 85.9% of executives.

ClassificationRankingPercentile
All
1,965
out of 13,971
86th
Division
Manufacturing
715
out of 5,692
87th
Major group
Chemicals And Allied Products
217
out of 2,189
90th
Industry group
Drugs
174
out of 1,875
91st
Industry
Biological Products, Except Diagnostic Substances
42
out of 389
89th

Pay ratio

John G. McHutchison's Pay$5,435,962
Median Employee's Pay$173,264
Pay Ratio

31

to 1

In 2019, the annual total compensation of John G. McHutchison was $5,435,962.

The annual total compensation of the median employee at Gilead Sciences was $173,264.

The ratio of John G. McHutchison's pay to the pay of median employee was therefore 31 to one.

Source: SEC filing on March 24, 2020.

McHutchison's colleagues

We found eight more compensation records of executives who worked with John G. McHutchison at Gilead Sciences in 2019.

2019

Daniel O'Day

Gilead Sciences

Chief Executive Officer

2019

Johanna Mercier

Gilead Sciences

Chief Commercial Officer

2019

Gregg Alton

Gilead Sciences

Chief Executive Officer

2019

Laura Hamill

Gilead Sciences

Former Executive Vice President Worldwide Commercial Operations

2019

Robin Washington

Gilead Sciences

Chief Financial Officer

2019

Andrew Dickinson

Gilead Sciences

Chief Financial Officer

2019

Brett Pletcher

Gilead Sciences

General Counsel

2019

Merdad Parsey

Gilead Sciences

Chief Medical Officer

News

You may also like